X0306 4 2020-10-30 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001397906 Cha Albert C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2020-10-30 4 P 0 68255 17.1681 A 1090748 I By Vivo Opportunity Fund, L.P. Common Stock 2020-10-30 4 P 0 47431 17.3359 A 1138179 I By Vivo Opportunity Fund, L.P. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.26 to $17.25 per share, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The shares are held of record by Vivo Opportunity Fund, L.P. The general partner of the holder is Vivo Opportunity, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.26 to $17.35 per share, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Benjamin L. Palleiko 2020-11-03